Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • allergens (2)
  • case control studies (1)
  • cryptomeria (1)
  • female (1)
  • humans (1)
  • japan (1)
  • nasal (1)
  • nasal symptoms (7)
  • patients (7)
  • pollen (3)
  • pollinosis (6)
  • rhinitis (6)
  • sino (1)
  • sleep (6)
  • Sizes of these terms reflect their relevance to your search.

    Japanese cedar (JC) pollinosis is the most common seasonal allergic rhinitis (AR) in Japan. AR reduces the quality of life not only because of nasal symptoms but also because of sleep disturbance. In the present study, we investigated the effects of sublingual immunotherapy (SLIT) with a standardized JC pollen extract on nasal symptoms and AR-related sleep disturbance in patients with JC pollinosis. In the present non-randomized controlled study, we assigned thirty-one patients with JC pollinosis who received SLIT into the SLIT group, and another thirty-eight patients with JC pollinosis who visited our hospital without treatment into the untreated group. We evaluated nasal symptoms and sleep disturbance using the classification of the severity of AR symptoms and the Athens Insomnia Scale, respectively. The nasal symptom scores and the Athens Insomnia Scale scores of patients in the SLIT group were both significantly lower than those of patients in the untreated group. There was a significant correlation between total nasal symptom scores and the Athens Insomnia Scale scores. These findings suggested that SLIT with JC pollen extract suppressed nasal symptoms in patients with JC pollinosis, leading to improvements in AR-related sleep disturbance and daytime troubles with daily life. Copyright © 2021. Published by Elsevier B.V.

    Citation

    Tatsuya Fujii, Yoshiaki Kitamura, Seiichiro Kamimura, Keisuke Naito, Noriaki Takeda. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis. Auris, nasus, larynx. 2021 Aug;48(4):653-658

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33461852

    View Full Text